Nalaganje...
Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
Ibrutinib is approved for chronic lymphocytic leukemia (CLL). However, its role in the treatment of multiple myeloma (MM) is not clear and is under investigation. We report a case of CLL that developed MM while on therapy with ibrutinib indicating that this drug may not be active against MM.
Shranjeno v:
| izdano v: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7495781/ https://ncbi.nlm.nih.gov/pubmed/32983498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3019 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|